A B S T R A C T Bullous pemphigoid (BP) is associated with circulating autoantibodies reactive with an antigen(s) of the basement membrane zone (BMZ) of skin and mucosae. The pathogenicity of these autoantibodies, although suspected, is unconfirmed. We have investigated the effects of BP autoantibodies on a closely related tissue, the corneal epithelium of the rabbit. IgG fractions from the sera of seven patients with BP were purified by (a) ammonium sulfate precipitation, (b) ion exchange chromatography, or (c) gel filtration. Control IgG was prepared by ion exchange chromatography of pooled normal human gamma globulins. 32 rabbits received corneal intrastromal injections of BP IgG fractions (50 gl, 0.95-2.05 mg total dose) in one eye, and control IgG (50 ,ul, 1.8 mg)
A B S T R A C T Bullous pemphigoid (BP) is associated with circulating autoantibodies reactive with an antigen(s) of the basement membrane zone (BMZ) of skin and mucosae. The pathogenicity of these autoantibodies, although suspected, is unconfirmed. We have investigated the effects of BP autoantibodies on a closely related tissue, the corneal epithelium of the rabbit. IgG fractions from the sera of seven patients with BP were purified by (a) ammonium sulfate precipitation, (b) ion exchange chromatography, or (c) gel filtration. Control IgG was prepared by ion exchange chromatography of pooled normal human gamma globulins. 32 rabbits received corneal intrastromal injections of BP IgG fractions (50 gl, 0.95-2.05 mg total dose) in one eye, and control IgG (50 ,ul, 1.8 mg) in the contralateral cornea. 28 of 32 BP IgG injections produced corneal inflammatory lesions, 10 of which developed visible blisters. Histologically, lesions showed polymorphonuclear cells clustering along the BMZ, and subepithelial blister formation. Immunofluorescence showed in vivo bound IgG and C3 at the BMZ. The intensity of inflammation was dose dependent and correlated often with in vitro complement fixation titers of the fractions. None of 32 corneas injected with control IgG became inflamed. BP IgG fractions injected intradermally into the ear skin of rabbits failed to produce inflammation. This may be due to slow clearance of IgG in the cornea, and optimal binding by the corneal epithelium. The intracorneal injections of BP There is evidence that the circulating BP autoantibodies may be pathogenic in vitro. Recently, Gammon et al. (4) have shown that sections ofnormal human skin will fix BP autoantibodies, and when treated with a source of complement will produce attachment of peripheral blood leukocytes along the BMZ. However, systemic passive transfer of human BP plasma into animals had produced discouraging results (5) . In these studies it was possible to detect in vivo binding of BP antibodies at the BMZ, but neither bullae nor inflammation was produced.
We studied the effects of BP autoantibodies on the corneal epithelium of the rabbit when injected locally into the stroma of the cornea. Intrastromal corneal injection of BP IgG produces lesions that reproduce the clinical, histological, and immunological features of BP. To determine if the immunoglobulin fractions would produce inflammation when injected intradermally, three rabbits received intracorneal injections of BP IgG in one eye and contralateral control IgG injections. These rabbits received simultaneous injections of 100 ,l of the BP IgG fraction intradermally into the ear skin.
METHODS

RESULTS
Clinical evaluation. Immediately following injection, control and experimental eyes appeared identical. Inadvertent penetration of the anterior chamber occurred in six eyes and produced no differences when compared with uncomplicated injections. 48 h after injection, control corneas appeared unchanged except for slight scarring along the needle tract (Fig. lb) (Table I ). The intensity of the inflammation could be characterized as minimal, moderate, or severe. Minimal reactions consisted of epithelial thickening and anterior stromal edema persisting from 24 to 72 h post injection (7 of 28 positive reactions). Moderate inflammatory responses were characterized by intense epithelial and anterior stromal edema, with numerous microscopic lucent areas at the epithelial-stromal interface, (11, 28) . Severe reactions were characterized by clinically obvious blister formation, with separation of the epithelium from the stroma (10, 28). These corneas also developed a circular opaque ring at the margin ofthe injection that had the appearance ofa "Wessely ring" (Fig. lc) (7), and iritis with a ciliary flush and aqueous cell and flare.
Severe reactions occurred only with BP IgG fractions from patients 1, 2, and 3. Injections that failed to produce detectable inflammation were prepared from patients 4 and 5. The intensity of inflammation correlated with the in vitro complement fixation titers in these fractions (Table I) .
The inflammatory response of injected comeas was dose dependent. Injection of 1.9 mg of BP IgG from patient 1 produced severe inflammation, 1 (Figs.  2c and 2d) . Control comeas injected with normal human IgG showed only a minimal accumulation of inflammatory cells in the area of the limbus and no significant stromal infiltration (Fig. la) .
Immunofluorescence studies. Direct IF of BPinjected corneas 24 h postinjection showed linear deposition of IgG and C3 along the epithelial stromal junction (Fig. 2e) . This was not seen in control IgGinjected corneas.
Additional studies. Of the three rabbits that received simultaneous intradermal and intracorneal injections, all three developed characteristic and intense corneal inflammatory changes. None of these rabbits developed any clinically detectable inflammation in the area ofthe ear skin injected, there was no IgG or C3 deposition at the BMZ, and no significant inflammation histologically. Both BP and control IgG fractions were found to be free of detectable protease activity.
DISCUSSION
The injection of BP IgG-class autoantibodies produced an inflammatory reaction in the cornea localizing at the epithelial-stromal junction. IgG and C3 were bound along the BMZ, and there was attachment of polymorphonuclear cells at the BMZ, with subepithelial blister formation. Control IgG fractions injected in a similar volume and dose did not produce any detectable inflammation clinically or histologically, and did not show IgG or C3 binding at the BMZ. We found that the intensity of inflammatory changes induced by BP IgG fractions frequently correlated with the in vitro complement fixation titers. Those IgG fractions which had high in vitro complement fixation titers gave reproducibly intense inflammatory responses. Conversely, the only BP IgG fractions that failed to produce inflammatory lesions after injection showed equivocal or weakly positive complement fixation titers. There was a notable exception to this generality: the BP IgG fraction from patient 7. This fraction had undetectable BP In the disease state, BP, lesions develop on skin and mucous membranes, including conjunctival epithelium, yet lesions usually are not observed in the corneal epithelium. We speculate that this is due to the relative immunological isolation of the cornea (9) . Access of circulating antibodies to the corneal epithelium under normal circumstances is limited to (a) diffusion from vessels of the limbal circulation, (b) diffusion from the aqueous humor through the corneal endothelium and stroma, and (c) penetration through the tear film. IgG concentration in the aqueous humour ofthe humans ranges from 5 to 22 mg1100 ml, -100 times lower than in serum (10) . The major immunoglobulin of the tear film is IgA, not IgG, and penetration of immunoglobulin through an intact tear film is questionable. The precise amount of IgG that diffuses into the cornea from the limbal circulation is not known. It is conceivable, therefore, that the relative isolation ofthe corneal epithelium from circulating BP antibodies is responsible for the absence ofclinically detectable corneal disease in patients with BP. It is also possible that corneal involvement in BP is subtle and easily overlooked clinically, as postulated by Foster (11 
